Literature DB >> 23229971

The 'cost' of medication nonadherence: consequences we cannot afford to accept.

Marie A Chisholm-Burns1, Christina A Spivey.   

Abstract

OBJECTIVE: To provide a brief overview of the extent of medication nonadherence in the United States, its impact on patient health and health care costs, its causes, and possible strategies that health care practitioners can use to improve medication adherence.
SUMMARY: Medication use and health care costs have increased dramatically during the previous decade in the United States. Adherence to medication therapy often is a critical aspect of medical treatment, particularly the treatment of chronic conditions such as diabetes and hypertension. Despite the importance of adherence, medication nonadherence is a serious problem, with the World Health Organization noting that the average nonadherence rate is 50% among those with chronic illnesses. Consequences of nonadherence include worsening condition, increased comorbid diseases, increased health care costs, and death. Nonadherence results from many causes; therefore, no easy solutions exist. The first step to addressing nonadherence is to recognize that collaboration must occur between health care practitioners and patients to increase adherence, with the goal of achieving optimal health outcomes.
CONCLUSION: The relationship between health care practitioners and patients and open, ongoing communication between the stakeholders are essential to combating medication nonadherence. Given their training and accessibility, pharmacists are well positioned to address nonadherence.

Entities:  

Mesh:

Year:  2012        PMID: 23229971     DOI: 10.1331/JAPhA.2012.11088

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  36 in total

Review 1.  Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Hemal Bhatt; Monika Safford; Stephen Glasser
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

2.  Ideating Mobile Health Behavioral Support for Compliance to Therapy for Patients with Chronic Disease: A Case Study of Atrial Fibrillation Management.

Authors:  Mor Peleg; Wojtek Michalowski; Szymon Wilk; Enea Parimbelli; Silvia Bonaccio; Dympna O'Sullivan; Martin Michalowski; Silvana Quaglini; Marc Carrier
Journal:  J Med Syst       Date:  2018-10-13       Impact factor: 4.460

Review 3.  Monitoring drug adherence.

Authors:  Sarah R Lieber; Jacqueline Helcer; Eyal Shemesh
Journal:  Transplant Rev (Orlando)       Date:  2015-04       Impact factor: 3.943

Review 4.  Monitoring treatment adherence in hypertension.

Authors:  Serap Erdine; Eren Arslan
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

5.  Ingestible Biosensors for Real-Time Medical Adherence Monitoring: MyTMed.

Authors:  Peter R Chai; Rochelle K Rosen; Edward W Boyer
Journal:  Proc Annu Hawaii Int Conf Syst Sci       Date:  2016-01

6.  Measuring medication adherence in older community-dwelling patients with multimorbidity.

Authors:  San Kim; Kathleen Bennett; Emma Wallace; Tom Fahey; Caitriona Cahir
Journal:  Eur J Clin Pharmacol       Date:  2017-12-03       Impact factor: 2.953

7.  Patient and physician adherence in hypertension management.

Authors:  J Rick Turner
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-11       Impact factor: 3.738

8.  Remote intervention engagement and outcomes in the Clinical Trials in Organ Transplantation in Children consortium multisite trial.

Authors:  Sarah Duncan-Park; Claire Dunphy; Jacqueline Becker; Christine D'Urso; Rachel Annunziato; Joshua Blatter; Carol Conrad; Samuel B Goldfarb; Don Hayes; Ernestina Melicoff; Marc Schecter; Gary Visner; Brian Armstrong; Hyunsook Chin; Karen Kesler; Nikki M Williams; Jonah N Odim; Stuart C Sweet; Lara Danziger-Isakov; Eyal Shemesh
Journal:  Am J Transplant       Date:  2021-04-12       Impact factor: 8.086

9.  Effects of a Tailored Text Messaging Intervention Among Diverse Adults With Type 2 Diabetes: Evidence From the 15-Month REACH Randomized Controlled Trial.

Authors:  Lyndsay A Nelson; Robert A Greevy; Andrew Spieker; Kenneth A Wallston; Tom A Elasy; Sunil Kripalani; Chad Gentry; Erin M Bergner; Lauren M LeStourgeon; Sarah E Williamson; Lindsay S Mayberry
Journal:  Diabetes Care       Date:  2020-11-05       Impact factor: 19.112

10.  The relationship between personality disorder, depression and eating disorder with treatment adherence in patients with type 2 diabetes; a cross-sectional study in diabetic patients in Iran.

Authors:  Negar Jalali; Habibeh Taghavi Kojidi; Rahim Badrfam; Atefeh Zandifar
Journal:  J Diabetes Metab Disord       Date:  2021-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.